| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.043 | 0.8 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |